Dentsply Sirona News

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)

TipRanksMay 13 05:51

Stifel Nicolaus Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

TipRanksMay 8 21:09

Dentsply Sirona to Participate in Upcoming Investor Conferences

Yahoo FinanceMay 8 15:15

Dentsply Sirona Is Maintained at Neutral by Goldman Sachs

Dentsply Sirona Is Maintained at Neutral by Goldman Sachs

Dow JonesMay 6 10:45

Goldman Sachs: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from neutral to neutral, and adjusted the target price from $34.00 to $30.00.

Goldman Sachs: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from neutral to neutral, and adjusted the target price from $34.00 to $30.00.

Zhitong FinanceMay 6 10:40

Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $30

Goldman Sachs analyst Nathan Rich maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $34 to $30.

BenzingaMay 6 10:35

Dentsply Sirona Is Maintained at Outperform by Evercore ISI Group

Dentsply Sirona Is Maintained at Outperform by Evercore ISI Group

Dow JonesMay 3 11:34

Evercore ISI Group: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $40.00 to $35.00.

Evercore ISI Group: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $40.00 to $35.00.

Zhitong FinanceMay 3 11:31

Earnings Call Summary | Dentsply Sirona(XRAY.US) Q1 2024 Earnings Conference

The following is a summary of the DENTSPLY SIRONA Inc. (XRAY) Q1 2024 Earnings Call Transcript:Financial Performance:DENTSPLY SIRONA reported Q1 2024 revenue of $953 million, a decline of 2.6% from th

Futu NewsMay 3 11:25 · Conference Call

Evercore ISI Group Maintains Outperform on Dentsply Sirona, Lowers Price Target to $35

Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $40 to $35.

BenzingaMay 3 11:24

UBS Adjusts Price Target on Dentsply Sirona to $37 From $38, Maintains Buy Rating

Dentsply Sirona (XRAY) has an average outperform rating and a price target range of $27 to $42, according to analysts polled by Capital IQ. Price: 28.52, Change: +0.14, Percent Change: +0.49

MT NewswiresMay 3 10:54

Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Appear To Be Weighed Down

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and th

Simply Wall StMay 3 10:08

Research Alert: CFRA Reiterates Hold Opinion On Shares Of Dentsply Sirona Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target price by $1

MT NewswiresMay 3 10:05

DENTSPLY SIRONA: A Buy Rating With Positive Long-Term Growth Prospects Despite Short-Term Challenges

TipRanksMay 3 08:45

Challenging Growth and Market Pressures Lead to Hold Rating for DENTSPLY SIRONA

TipRanksMay 3 07:06

Dentsply Sirona Price Target Cut to $33.00/Share From $35.00 by Baird

Dentsply Sirona Price Target Cut to $33.00/Share From $35.00 by Baird

Dow JonesMay 3 06:14

Dentsply Sirona Is Maintained at Buy by Needham

Dentsply Sirona Is Maintained at Buy by Needham

Dow JonesMay 3 05:30

Needham Maintains Buy on Dentsply Sirona, Lowers Price Target to $36

Needham analyst David Saxon maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $42 to $36.

BenzingaMay 3 05:20

Needham: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from buy to buy rating, and adjusted the target price from $42.00 to $36.00.

Needham: Maintaining the Dentsply Sirona (XRAY.US) rating, adjusted from buy to buy rating, and adjusted the target price from $42.00 to $36.00.

Zhitong FinanceMay 3 05:20

Dentsply Sirona Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 26.85% Needham $42 → $36 Maintains Buy 04/18/2024 44.47% Barrington Research $41 → $41 Maintain

BenzingaMay 3 05:19